Sialorrhea, commonly known as drooling or excessive saliva production, refers to the uncontrolled dripping of saliva from the mouth. It occurs due to impaired control of saliva production from damage to the nerves that activate the salivary glands or nerves that stimulate swallowing. The growing prevalence of neurological diseases like Parkinson's disease, cerebral palsy, and motor neuron diseases where sialorrhea is a common symptom is driving the need for effective sialorrhea treatment options.
The sialorrhea treatment market is estimated to be valued at USD 771 Mn in 2024 and is expected to reach USD 1,110 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.30% from 2024 to 2031.
Key Takeaways
Key players operating in the Global Sialorrhea Treatment Market include Merz Pharmaceuticals, US WorldMeds, NeuroHealing, Proveca, and Eisai (via Sloan Pharma). Merz Pharmaceuticals offers Xeomin injection for sialorrhea treatment.
Growing awareness about available treatment options and supportive reimbursement policies in developed markets present lucrative opportunities for Global Sialorrhea Treatment Market players. Adoption of minimally invasive treatment devices can further expand the market reach.
Key players are investing in R&D to develop novel drugs and devices for more effective management of sialorrhea. Several clinical trials are also evaluating the efficacy of new drug candidates and delivery mechanisms. This will help companies strengthen their presence across global markets.
Market drivers
The rising prevalence of neurological disorders due to aging population is a major market driver. According to some estimates, over 7 million people in the US will be living with Parkinson's disease by 2060. Sialorrhea profoundly impacts the quality of life of patients and caregivers. Effective treatment can aid better disease management.
PEST Analysis
Political: Regulations around drug approval and pricing have an impact on the market. Drug makers need to ensure compliance with rules around testing, clinical trials, and pricing of new or existing treatments.
Economic: Trends in the broader economy, including GDP growth, influence healthcare spending and demand for new treatments. Average incomes also impact accessibility and affordability of newer drugs.
Social: Growing awareness about conditions like Alzheimer's and Parkinson's diseases drive focus on finding new treatment solutions. As patients and families deal with issues like excess saliva formation, they look for newer therapies to help manage symptoms better.
Technological: Advancements in drug design and delivery systems facilitate development of more targeted therapies. Research into molecular pathways also aid development of therapies tailored to specific patient subgroups. Companies introducing less invasive delivery methods can gain an edge.
Geographical Regions of Concentration
North America accounts for the largest share of the global sialorrhea treatment market in terms of value. This can be attributed to factors like presence of major market players, higher healthcare spending, and growing elderly population susceptible to neurological conditions in countries like the US and Canada.
Fastest Growing Region
Asia Pacific region is projected to witness the fastest growth during the forecast period. This is fueled by rising geriatric population, improving access to modern healthcare facilities, and growing disposable incomes in emerging economies of China, India, Japan and others. Favorable government policies to strengthen healthcare infrastructure also boost prospects in Asia Pacific region.
Get This Report in Japanese Language: 世界の流汗症治療市場
Get This Report in Japanese Language: 글로벌 타액치료 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
(https://www.linkedin.com/in/ravina-pandya-1a3984191)
